Great work by The George Institute for Global Health PhD fellow Jeffrey Ha - systematically defining the progressive, graded increase in risk of atrial fibrillation as kidney function declines and as albuminuria increases Now out in AJKD: ajkd.org/article/S0272-…

Our systematic review in AJKD - CKD should be regarded as an independent risk factor for new-onset atrial fibrillation. We should consider screening for AF in CKD #cardiorenal @badves Dearbhla Kelly Brendon Neuen Min Jun Vlado Perkovic ajkd.org/article/S0272-…

Big news: the FLOW trial of semaglutide for kidney protection in CKD stopped at pre-planned interim analysis. Trial now to close out and results will be available in first half of 2024. #FLOWtrial #semaglutide #ozempic

IMJ October (Vol 53, Iss 10) is now online bit.ly/497JPZ9 Jeff Szer The Royal Australasian College of Physicians Wiley Clinical Health Daniel Steinfort @ianjohnwoolley2 james o'beirne @cancersolutions SaurabhKumar, MBBS, PhD, FCSANZ, FRACP, FHRS Sunil Badve Sze Ting Lee @Velandaisrikan1 Yvonne Bonomo

IMJ October 2023 #OpenAccess Review: Revisiting resistant hypertension bit.ly/46zqjDr Jeff Szer The Royal Australasian College of Physicians Wiley Clinical Health Sunil Badve Swapnil Hiremath @[email protected] Ottawa Renal Ryan Chan

Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis buff.ly/3Q22tca Jeffrey Ha Dearbhla Kelly Brendon Neuen Vlado Perkovic Min Jun Sunil Badve The George Institute for Global Health UNSW Medicine & Health #VisualAbstract

With Sunil Badve Prakash Gudsoorkar at the ANIO get-together at the #KidneyWk

RENAL LIFECYCLE Trial: Efficacy and safety of dapagliflozin 10 mg vs placebo #Nephpearls ✅ eGFR <25 ✅ Patients on dialysis with residual diuresis >500 ml/24-hour ✅ Kidney transplant recipients with an eGFR </=45 📌 PRIMARY ENDPOINT: Composite end point of kidney failure,

IMJ November (Vol 53, Iss 11) is now online bit.ly/3GeDWfK Jeff Szer The Royal Australasian College of Physicians Wiley Clinical Health Daniel Steinfort @ianjohnwoolley2 james o'beirne @cancersolutions SaurabhKumar, MBBS, PhD, FCSANZ, FRACP, FHRS Sunil Badve Sze Ting Lee @Velandaisrikan1 Yvonne Bonomo Richard Skoien @defineCPRbetter

The new 2023 ACC/AHA/ACCP/HRS #AFib Guideline-at-a-Glance highlights the new classification system of AF, which identifies AF as a disease continuum that requires a variety of strategies at different stages. Learn more: bit.ly/3sYdow8 #ClinicalGuidelines #CardioTwitter

Cosmic kidney disease: happy to offer my services nature.com/articles/s4146…

Check out our latest publication in NDT on the meta-epidemiology of heart failure events in RCTs for adults receiving maintenance dialysis academic.oup.com/ndt/advance-ar…

Great & provocative read for all nephrologists by Prof. Toussaint and Sunil Badve: "Addressing only 1 factor (...) and assuming that lowering serum phosphate alone is of major importance are superficial and ignoring complexities." We eagerly await PHOSPHATE😎 kidney-international.org/article/S0085-…

New in NEJM Evidence! Original Article by Jeffrey Ha et al.: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease eviden.cc/3z2CLzM Sunil Badve Min Jun Swapnil Hiremath @[email protected] Daniel Coyne Suetonia Palmer David C Wheeler Vlado Perkovic The George Institute for Global Health UNSW Medicine & Health

Comprehensive review by Drs. Yeung, Toussaint & Sunil Badve "We do not recommend routine use of vit D supplementation in (...) CKD stages 3–5, although in those with 25(OH)D deficiency there may be some rationale for replacement as benefit may outweigh harm" academic.oup.com/ckj/article/17…

In addition to the late-breaking FINEHEART finerenone pooled IPD data in HFpEF & CKD from Muthu Vaduganathan in HOTLINE 7, join us for multiple kidney-related presentations at #ESCCongress Kidney data from DELIVER, PARAGON, TOPCAT, I-PRESERVE, CANVAS & CREDENCE trials & much more

GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in Circulation for #ESCCongress ahajournals.org/doi/abs/10.116…

New analysis from CANVAS and CREDENCE trials reveals a bidirectional relationship between CV events and #CKD progression in type 2 #diabetes bit.ly/3X747wK #ESCCongress #JACC #T2D #MACE Brendon Neuen Muthu Vaduganathan

Pooled data from ~15,000 pts in 4-RCTs examining the relationship b/w NT-proBNP, kidney function & outcomes in HFpEF Data which calls into question proposals for higher NT-proBNP references ranges in people with CKD #Simpub in JACC-HF for #ESCCongress sciencedirect.com/science/articl…

OCEANIC-AF stopped early due to inferiority of factor XI inhibitor asundexian vs. apixaban in AFib. Download slides presented at #ESCCongress here: clinicaltrialresults.org/wp-content/upl…